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After intradermal infection of mice with the obligatory intracellular parasite Leishmania major,
Langerhans cells (LC) are intimately involved in the induction of the primary T-cell immune
response. LC can phagocytose Leishmania and transport ingested parasites from the infected skin
to the regional lymph nodes. Since TNFa and IL-1/3 have been shown to induce LC migration
after epicutaneous exposure to skin-sensitizing chemicals, we investigated the involvement of
both cytokines in the migration of Leishmania-infected LC. In addition, the relevance of two
chemokines of the/3 subfamily, macrophage inflammatory protein o (MIP- c0 and macrophage
chemoattractant protein (MCP-1), was analyzed. In vivo depletion of TNFa significantly
reduced the amount of infected LC and the parasite load in the draining lymph nodes.
AdministratiQn of recombinant TNFo caused the reverse effect. In contrast, the depletion of IL-
l/3 enhanced the parasite-induced LC migration, whereas treatment with recombinant IL-1/3, as
well as recombinant MIP- c, reduced the rate of infected LC in the lymph nodes. MCP- did not
influence LC migration. Our data demonstrate that TNFa and IL-1/3 are regulating the LC-
mediated transport of Leishmania and also provide evidence for the involvement of macrophage
attractant chemokines in this process.
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INTRODUCTION
Epidermal Langerhans cells (LC), as members of the
dendritic-cell lineage, are part of a system of potent
antigen-presenting cells in skin and lymph nodes
(Steinman, 1991). Dendritic cells constitutively
express MHC class II molecules and have the unique
ability to induce primary T-cell responses. Upon
stimulation with skin-irritating chemicals or after skin
transplantation, LC leave the skin and migrate via the
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lymphatics into the lymph nodes, draining the site of
epicutaneous exposure (Macatonia et al., 1987;
Larsen et al., 1990). During this migration, LC are
subject to a functional and phenotypic differentiation
that is thought to be initiated by epidermal cytokines.
They develop into highly efficient antigen-presenting
cells with the potential to induce the primary
stimulation of specific T cells.
Recent studies revealed that the induction of an
antigen-specific T-cell immune response after cuta-
neous infection with the obligatory intracellular
parasite Leishmania major is mediated by epidermal
LC (Moll et al., 1993, 1995). LC can phagocytose L.
major and transport them from the skin to the local
lymph nodes for presentation of parasite antigen to
resting T cells. LC produce cytokines such as
interleukin-lfi (IL-lfl) and the chemokine macro-
phage inflammatory protein 1c (MIP-1 c0 (Heufler et
al., 1992; Schreiber et al., 1992). Furthermore,
keratinocytes in the skin epidermis release tumor
necrosis factor c (TNFc0 and granulocyte/macro-
phage-colony stimulating factor (GM-CSF) that are
critical for the viability and differentiation of LC
(Koch et al., 1990). However, the factors regulating
LC migration are not completely understood. In this
study, we analyzed the role of TNFa and IL-lfl in
Leishmania-induced LC migration. Furthermore, the
influence of the chemokines MIP-1c and macrophage
chemoattractant protein 1 (MCP-1) was investigated.
Both chemokines are involved in skin-associated
inflammatory processes and were recently shown to
be important markers for the classification of different
clinical forms of human cutaneous leishmaniasis
(Ritter et al., 1996). Recombinant cytokines or
neutralizing antibodies were administered in vivo,
prior to or simultaneously with infection with the
parasite. The amount of infected LC migrating to the
lymph nodes was estimated by double-staining tech-
niques. In addition, the frequency of parasite-infected
cells in the regional lymph nodes was determined in a
limiting dilution assay. To distinguish the effects of
locally produced mediators from those of exogenous
sources on LC migration, we additionally used a skin
explant culture system.
RESULTS
Detection of L. major-Containing Dendritic Cells
In the first experiments, we defined the time point that
is suitable for detection of parasite-bearing LC
arriving in lymph nodes draining the site of infection.
As early as 2 days after intradermal infection of mice
with L. major promastigotes, significant numbers of
parasite-containing cells could be identified in lymph
node sections using a double-staining technique
(Figure 1). This time point was used in all experi-
ments to evaluate the effects of TNFc, IL-lfl, MIP-
1 a, and MCP-1 on LC migration. It is of particular
importance that at this early time point, Leishmania
parasites only can be found in lymph node dendritic
cells and are not associated with macrophages (Moll
et al., 1993).
TNFc Enhances the Leishmania-Induced LC
Migration
To determine whether TNFce has an effect on the
migration rate of infected LC, mice were treated with
recombinant TNFce and, at the same time, were
infected intradermally with L. major parasites. Two
days after treatment, the lymph nodes draining the site
of infection were removed and immunohistochemical
double staining was performed to enumerate infected
dendritic cells. Figure 2 illustrates that the administra-
tion of recombinant TNFce enhanced the number of
parasite-bearing dendritic cells in the lymph nodes
nearly twofold as compared to control mice that
received normal serum. In order to confirm the
involvement of TNFce in the induction of LC
migration, mice were treated with neutralizing anti-
TNFce antibodies, 2 hr before infection with the
parasite. The depleting antibodies were applied intra-
peritoneally and not locally to avoid antibody-induced
changes in the content ofLC at the site of exposure to
the parasite (unpublished observation). As shown in
Figure 2, the in vivo depletion of TNFce resulted in a
pronounced reduction of infected LC in the lymph
nodes. It should be noted that LC migration could not
be totally inhibited by in vivo depletion of TNFce.6 J. ARNOLDI and H. MOLL
significantly change the frequency of infected lymph
node cells. Thus, the cytokine-induced changes in LC
migration correlate with those in the parasite load of
the draining lymph nodes.
Skin Explant Cultures Show that TNFc and IL-
l/3 Act as Local Mediators in the Skin
Next, we wanted to investigate whether the influence
of TNFc and IL-1 fi on LC migration is dependent on
the infection with Leishmania parasites. Furthermore,
we wanted to analyze the effects of cytokine treat-
ment on the local environment in the skin. To exclude
the involvement of exogenous mediators, released by
infiltrating cells, we harvested the skin areas immedi-
ately after administration of recombinant TNFa or IL-
lf alone or in combination with L. major promasti-
gotes. The skin explants were placed onto medium in
3-ml wells and, after 4 days of culture, the emigrated
cells were immunostained for dendritic cell markers.
As demonstrated in Table 2, the administration of IL-
lf i TNFa, parasites or phoshate-buffered saline
(PBS) alone induce an enhanced LC emigration, as
compared to untreated controls. Interestingly, the
amount of emigrated dendritic cells was significantly
lower than the PBS-treated group after combined
treatment with L. major parasites and recombinant IL-
lfl On the other hand, only the combined administra-
tion of TNFc with Leishmania parasites significantly
enhanced the rate of emigrated LC. Thus, these data
confirm the results obtained from the analysis of
lymph nodes and, in addition, show that TNFo acts
locally to enhance the LC-mediated export of L.
major from the skin, whereas IL-lfi reduces this
process.
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FIGURE 2 The migration of L. major-infected LC is modulated by cytokines and chemokines. The microscopical quantification of infected
LC in lymph node sections after administration of control serum, neutralizing antibodies, or recombinant cytokines/chemokines and
intradermal infection with 10 L. major promastigotes. Forty-eight hours after infection, serial sections were subjected to double-staining
immunohistology for detection ofNLDC-145 cells expressing L. major antigen. The data represent means SD of 10 random fields at 400
magnification. Two additional experiments gave similar results.
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TABLE Frequency of Lymph Node Cells Infected with Leishmania Parasites
Treatment of mice Frequency (X 106) 95% Confidence limits (reciprocal values)
Control serum 1/8.5 6.4-9.0
Anti-TNFce 1/33.9 20.5-68.9
rTNFce 1/4.5 3.5-6.2
Anti-IL-lfl 1/2.2 1.6-3.1
rlL-lfi 1/24.2 15.6-53.5
rMIP-1 ce 1/12.7 10.2-22.1
rMCP-1 1/6.8 5.3-9.9
Note: Limiting dilution analysis of total lymph node cells after administration of neutralizing antibodies, recombinant cytokines/chemokines,
or control serum and intradermal infection with 10 L. major promastigotes. Forty-eight hours after infection, single-cell suspensions
were prepared and serial dilutions were incubated in blood agar cultures. Seven days later, the proportion of Leishmania-negative cultures
was determined. The experiments were repeated three times with similar results.
TABLE II Emigration of LC from Skin Explant Cultures
In vivo treatment Number of NLDC-145 cells/100 cells
None 0.5 0.08
PBS 1.6 0.5
rlL- fi 1.8 0.3
L. major + rlL-lfl 0.8 0.1
rTNFce 2.2 0.4
L. major + rTNFce 2.6 0.4
Note: Microscopical evaluation of epidermal dendritic cells that have emigrated from skin explants. Prior to culture in Click’s RPMI
medium, the skin was intradermally infected with 10 L. major parasites. Simultaneously, recombinant cytokines were administered.
Four days after skin explantation, emigrated dendritic cells were harvested from the bottom of the wells and immunocytochemically detected
by the APAAP technique. The data represent means SD of 10 random fields at 400 magnification and two sets of experiments.
DISCUSSION
The rapid emigration of LC from the epidermis and
their consecutive accumulation in the paracortical
areas of the draining lymph nodes after sensitization
with alloantigens or contact allergens has been
demonstrated previously in different systems (Mac-
atonia et al., 1987; van Wilsem et al.; 1994, Kimber
and Cumberbatch, 1995). Recent studies have
extended these observations by showing that not only
allergens, but also the skin-associated protozoan
parasite L. major can induce this migration (Moll et
al., 1993). Cytokines, in particular TNFc, have been
suggested to be involved in this phenomenon. Follow-
ing topical exposure to skin-sensitizing chemicals, the
administration of TNFce, a potent immunomodulatory
molecule, causes a reduction in the density of LC in
the skin and an increase in the number of antigen-
bearing LC in the draining lymph nodes in a
concentration- and time-dependent manner (Cumber-
batch and Kimber, 1992). The administration of
neutralizing anti-TNFce antibodies, on the other hand,
inhibits dendritic cell accumulation in lymph nodes
(Cumberbatch and Kimber, 1995). Furthermore,
TNFa was shown to directly influence LC function by
maintaining their viability in culture (Koch et al.,
1990). Our results presented here, using the skin-
associated parasite L. major, extend these data to an
infectious disease model and provide strong evidence
that TNFce is an important signal inducing the
migration of antigen-bearing LC in cutaneous leish-
maniasis. The in vivo depletion of TNFce caused a
pronounced reduction in the number of infected
dendritic cells and the parasite load in the draining
lymph nodes. As demonstrated in vivo and in skin
explant cultures, the administration of recombinant
TNFa caused the reverse effect. These data show that
TNFce is a locally induced mediator of LC migration8 J. ARNOLDI and H. MOLL
not only after contact sensitization, but also after
intradermal infection with parasites. A recent model
to explain LC migration after antigenic stimulation is
based on the interaction of LC with keratinocytes,
which are known to be the major source of TNFa in
the skin (Schreiber et al., 1992). Since LC have been
suggested to express the TNF receptor type II (p75),
they may respond to TNF released from keratinocytes
(Wang et al., 1996). This may result in the activation
of protein kinase C, which transduces the signal for
LC migration from the epidermis (Halliday and
Lucas, 1993).
Epidermal LC have been identified as the major
source of IL-lfi production in the epidermis (Heufler
et al., 1992; Schreiber et al., 1992). Following
epicutaneous skin sensitization, IL-lfl secretion can
be induced within minutes. Paracrine and autocrine
mechanisms cause the upregulation of MHC class II
expression on LC and enhancement of their immunos-
timulatory potential for resting T cells (Heufler et al.,
1988, Nylander-Lundqvist and Bick, 1990). This is
consistent with the finding that the in vivo depletion of
IL-lfi by monoclonal antibodies completely prevents
sensitization to allergens (Enk et al., 1993). Further-
more, there is evidence that IL-lfl can induce LC
migration (Kimpgen et al., 1995). These findings
were further substantiated by the use of IL-lfl-
deficient mice, which showed defective contact
hypersensitivity responses to topically applied skin
sensitizers (Shornick et al., 1996). In the present
study, we analyzed the role of IL-lfl in Leishmania-
induced LC migration by the use of recombinant IL-
lf or neutralizing anti-IL- 1 fi antibodies. Administra-
tion of the recombinant cytokine was expected to
enhance the parasite-induced LC migration. Inter-
estingly, however, the injection of IL-lfl reduced the
migration rate of L. major-infected LC in vivo. The
depletion of the cytokine caused the reverse effect. As
demonstrated in skin explant cultures, this phenome-
non was strongly dependent on the presence of
parasites, because the application of IL-lfl alone
resulted in an enhancement of LC emigration and,
thus, had an effect that was similar to the nonspecific
response after PBS injection. The observed reduction
in the number of parasite-containing LC leaving the
skin and reaching the lymph node after treatment with
IL-lfl can most likely be explained by a decrease in
the phagocytic activity of LC. The presence of
recombinant IL-lfl significantly reduced the propor-
tion of L. major-infected LC in vitro in a dose-
dependent manner (data not shown). Blocking this
inhibitory effect of IL-1 fl in vivo, by administration of
anti-IL-lfl antibodies, may result in an enhanced
capacity to phagocytose parasites, and in consequence
would increase the percentage of infected LC migrat-
ing to the lymph nodes. Therefore, our findings
suggest that the detrimental role of IL-1 fi in L. major
infection is not only caused by the selective activation
of T helper 2 over T helper 1 cells (Chakkalath and
Titus, 1994), but is also due to a decreased rate of
parasite phagocytosis and transport by LC in the very
early phase of infection, which is critical for the
primary stimulation of specific T cells.
The chemokine MIP-lce, primarily secreted by
stimulated macrophages, additionally is expressed by
epidermal LC (Matsue et al., 1992). MIP-1 ce causes
local inflammatory reactions and can regulate epi-
dermal homeostasis by inhibiting keratinocyte colony
formation. Thus, LC, as the major source of MIP-1 ce
in the epidermis, can downregulate keratinocyte
proliferation (Heufler et al., 1992). Keratinocytes, the
overwhelming majority of epidermal cells, have been
shown to be important inducers ofLC maturation and
differentiation (reviewed in Kimpgen et al., 1995).
This implies that inhibition of keratinocyte function
results in a reduced ability to stimulate LC and, in
consequence, may diminish the antigen-induced
differentiation and migration of LC. This hypothesis
is in line with our data demonstrating that intradermal
administration of MIP-lce, in combination with L.
major parasites, decreased the number of antigen-
bearing dendritic cells and the parasite load in the
draining lymph nodes.
In conclusion, our observations extend the impor-
tant roles of TNFce, IL-lfl, and MIP-1 ce in the
regulation of LC migration to an infectious disease
model. They also show that IL-lfl has a differential
role in this process, because it supports LC migration
in contact sensitization with haptens, whereas itLANGERHANS CELL MIGRATION IN LEISHMANIASIS 9
inhibits the transport of the intracellular parasite L.
major by reducing the phagocytic activity of LC.
MATERIAL AND METHODS
phatase (APAAP) complexes were purchased from
Dako (Hamburg, Germany). An immunogold-conju-
gated goat anti-rabbit immunglobulin antibody
(Amersham, Braunschweig, Germany) served as sec-
ond-stage reagent for silver-enhanced staining.
Mice
Female mice of the inbred strain BALB/c were 8 to 10
weeks of age at the onset of experiments. All mice
were purchased from Charles River Breeding Labora-
tories (Sulzfeld, Germany) and, during experimenta-
tion, were maintained under specific pathogen-free
(SPF) conditions in an isolation facility.
Parasites and Infection of Mice
The origin, culture, and propagation of the L. major
isolate (MHOM/IL/81/FE/BNI) have been described
elsewhere (Solbach et al., 1986). Promastigotes were
grown in vitro in blood agar cultures. Stationary-
phase promastigotes were washed in PBS and, for
intradermal infection of mice, 1 106 organisms
were injected in a volume of 10 /zl on the dorsum,
using a 100-/xl Hamilton syringe mounted with a
30-gauge Yale needle.
Antibodies and Cytokines
Polyclonal rabbit anti-mouse TNFce antiserum,
recombinant murine TNFce, and IL-1/3 were pur-
chased from Genzyme (Cambridge, MA), and goat
anti-murine IL-1/3 was a gift from-R&D systems
(Wiesbaden, Germany). Recombinant MIP-lce and
MCP-1 were products from R&D systems. Rat
monoclonal antibodies (mAb) against nonlymphoid
dendritic cells, from hybridoma NLDC-145, as well
as the isotype control antibodies, were from Dianova
(Hamburg, Germany). Polyclonal antibodies to L.
major were raised in rabbits by subcutaneous and
intramuscular injections of promastigotes in Com-
plete Freund’s adjuvans (CFA) followed by several
boosters of promastigotes in Incomplete Freund’s
adjuvans (IFA) and collection of the serum. Goat anti-
rat immunoglobulin antiserum was obtained from
Dianova, and alkaline phoshatase anti-alkaline phos-
Animal Treatment
All animal manipulations, other than antibody treat-
ment, were performed under metofane anesthesia
(Janssen, Neuss, Germany). Antibodies against TNFa
and IL-1/ were injected intraperitoneally (1 mg/
mouse) 2 hr before infection with L. major parasites.
The recombinant cytokines and chemokines were
injected intradermally (50 ng/mouse) simultaneously
with the parasites. Control mice received normal
serum at equivalent concentrations. All preparations
were diluted with sterile PBS and administered in a
total volume of 10/1.
Skin Explant Culture
Immediately after intradermal injections of L. major
promastigotes and/or recombinant cytokines onto the
shaved dorsum of BALB/c mice, skin explants of 10
mm2 were transferred to 12-well plates and cultured
in Clicks RPMI containing 10% FCS. After 4 days,
the emigrated cells were harvested from the bottom of
the wells and cytospins were prepared for subsequent
immunostaining.
lmmunostaining
For immunohistological identification of L. major-
containing cells, lymph nodes were snap-frozen in
OCT compound (Miles, Naperville, IL). Cryostat
sections (4-6 #m) as well as cytospins were fixed in
4% paraformaldehyde for 20 min, followed by
extensive washings in PBS. Nonspecific binding sites
were blocked by incubation in Blotto (PBS containing
10% skim milk powder and 0.1% bovine serum
albumin [BSA], fraction V) supplemented with 10%
FCS for 30 min at room temperature. Mixed labeling10 J. ARNOLDI and H. MOLL
of tissue sections was performed by incubation with
the primary antibodies diluted in Blotto for 1 hr
followed by treatment with goat anti-rat immuno-
globulin antiserum diluted in Blotto (30 min) and the
APAAP complex diluted in PBS (30 min). After
incubation with immunogold-labeled immuno-
globulin antiserum diluted in Blotto for 30 min,
the APAAP staining was developed with New
Fuchsin (Cordell et al., 1984). After postfixation in
2% glutaraldehyde and extensive washings in aqua
bidest, immunogold signals were detected by silver
enhancement according to the manufacturer’s
instructions (Amersham). Finally, slides were coun-
terstained with hematoxylin and mounted in Kaisers
glycerin gelatine (Merck, Darmstadt, Germany).
All immunostainings were controlled by (1) the use
of secondary reagents alone, to confirm their species
specificity; (2) the development of alkaline phospha-
tase alone, to exclude staining due to endogeneous
enzyme activity; and (3) the use of rat and rabbit
isotype control antibodies. All control stainings
yielded negative results.
Limiting Dilution Assay
Groups of three mice were used to determine the
parasite load in the draining lymph nodes, 2 days after
intradermal infection with L. major. Single-cell
suspensions were prepared and lymph node cells were
resuspended in Clicks RPMI containing 10% FCS.
Serial dilutions ranging from 1 108 to 1 103 cells/
well (20 replicate cultures per dilution) were incu-
bated in blood agar microcultures to support the
growth of parasites. After 7 days of incubation at
28C, the cultures were scored for the presence of
parasites using an inverted microscope. Minimal
estimates of the frequencies of L. major-infected cells
and the 95% confidence intervals were calculated
according to the minimum Xz method from the
Poisson distribution relationship between the number
of lymph node cells and the logarithm of the fraction
of Leishmania-negafive cultures by using a computer
program (Taswell, 1987).
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